Sign Up to like & get
recommendations!
0
Published in 2017 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofx163.905
Abstract: Abstract Background Eravacycline (ERV is the first fully synthetic fluorocycline with activity against tetracycline (TET)-resistant organisms. In addition, it is 2–8 times more potent than tigecycline (TGC). Like other tetracyclines, it inhibits protein synthesis by…
read more here.
Keywords:
vitro activity;
tgc;
erv;
eravacycline ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.00275-18
Abstract: Eravacycline (7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline or TP-434) is a novel, fully synthetic broad-spectrum fluorocycline with potent activity against Gram-positive bacteria, anaerobes, and multidrug-resistant Enterobacteriaceae. We characterized the plasma pharmacokinetics of eravacycline and conducted a comprehensive analysis of the…
read more here.
Keywords:
tissue distribution;
analysis;
comprehensive analysis;
concentrations highest ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Journal of Clinical Microbiology"
DOI: 10.1128/jcm.01650-22
Abstract: Eravacycline (ERV) (brand name Xerava [Tetraphase]) is a new tetracycline-class antibacterial that has been approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for treatment of complicated intra-abdominal infections…
read more here.
Keywords:
multicenter clinical;
evaluation;
etest erv;
susceptibility testing ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Microbiology Spectrum"
DOI: 10.1128/spectrum.00718-23
Abstract: The antimicrobial activities of four third-generation tetracycline-class drugs, omadacycline (OMC), eravacycline (ERC), tigecycline (TGC), and sarecycline (SAC), were determined for 193 M. abscessus isolates. The activities of the four drugs at two different temperatures (30°C…
read more here.
Keywords:
tgc;
tigecycline;
abscessus activity;
abscessus ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Microbiology Spectrum"
DOI: 10.1128/spectrum.01390-22
Abstract: The increasing bacterial antibiotic resistance is a serious threat to global public health, which demands novel antimicrobial medicines and treatment strategies. Eravacycline is a newly approved antibiotic that belongs to the tetracycline antibiotics. ABSTRACT The…
read more here.
Keywords:
aztreonam avibactam;
development;
combination;
resistance eravacycline ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-7734
Abstract: Objective: Calcineurin inhibitors (CNIs) are standard prophylaxis for acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Given their narrow therapeutic window and variable bioavailability, rigorous therapeutic drug monitoring is mandatory, particularly during…
read more here.
Keywords:
drug drug;
administration;
drug;
efficacy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "BMC Microbiology"
DOI: 10.1186/s12866-020-1722-1
Abstract: Background Acinetobacter baumannii is a multidrug-resistant (MDR) hazardous bacterium with very high antimicrobial resistance profiles. Outer membrane vesicles (OMVs) help directly and/or indirectly towards antibiotic resistance in these organisms. The present study aims to look…
read more here.
Keywords:
whole cell;
analysis;
outer membrane;
resistance ... See more keywords